Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls.

Authors

null

M. Morse

Duke University Medical Center, Durham, NC

M. Morse , D. Niedzwiecki , J. Marshall , C. R. Garrett , D. Z. Chang , M. Aklilu , T. S. Crocenzi , D. J. Cole , S. Dessureault , A. Hobeika , T. Osada , B. M. Clary , S. D. Hsu , G. Devi , A. Bulusu , R. Annechiarico , V. Chadaram , T. M. Clay , H. K. Lyerly

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Clinical Trial Registration Number

NCT00103142

Citation

J Clin Oncol 29: 2011 (suppl; abstr 3557)

Abstract #

3557

Poster Bd #

12E

Abstract Disclosures